ArticleArXiv2026
Toward Ultra-fast Treatments: Large Energy Acceptance Beam Delivery Systems and Opportunities for Proton Beam Therapy.
Article in ArXiv, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Treatment delivery is largely determined by capabilities of the beam delivery system (BDS), where faster delivery can have many potential benefits including improved dosimetric quality, utility, cost effectiveness, patient throughput and comfort. Despite significant developments in accelerators, delivery methodologies, dose optimisation and more, the energy layer switching time (ELST) is still a persisting limitation in existing BDS. The ELST can contribute significantly to beam delivery time (BDT) and extend treatment times, requiring compensation by optimisation planning approaches, motion mitigation strategies, or active beam modification. This fundamental constraint can be addressed by increasing the narrow energy acceptance range of conventional beamlines to minimise the ELST, enabling ultra-fast delivery. A large energy acceptance (LEA) BDS has the potential to revolutionise PBT through immediate improvements to current treatment delivery and emerging delivery modalities: the complete exploitation of PBT - and unlocking its full potential - can only be made possible with advances in beam delivery technologies. We review the abundant opportunities offered by an ultra-fast BDS: shorter treatment times, reduced motion induced dose degradation, improved effectiveness of motion management techniques, possibilities for volumetric rescanning, bidirectional delivery, further planning optimisation, and novel delivery strategies. We overview the design concepts of several LEA proposals, technology requirements, and also discuss the remaining challenges and considerations with realising a LEA BDS in practice. There are multiple avenues requiring further development and study, however the clinical potential and benefits of this enabling technology are clear: ultra-fast delivery offers both immediate and future improvements to PBT treatments.
Identifiers
41647206PMC12869403What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.